title: The efficacy of drotrecogin alfa depends on severity of illness.
authors.forename: Katherine J
authors.initials: KJ
authors.lastname: Deans
authors.forename: Peter C
authors.initials: PC
authors.lastname: Minneci
authors.forename: Peter Q
authors.initials: PQ
authors.lastname: Eichacker
authors.forename: Charles
authors.initials: C
authors.lastname: Natanson
mesh_terms: D018806:APACHE; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D006295:Health Resources / Q000706:statistics & numerical data; D017052:Hospital Mortality; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012107:Research Design; D018805:Sepsis / Q000188:drug therapy / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated